MedicaidCoverageMedium impact
Updates to Coverage and Reimbursement of COVID-19 Products
Nevada Medicaid·NV · Family Medicine, Internal Medicine, General Practice +2 more·Reimbursement
Effective date
Oct 1, 2024
We identified it
Jun 21, 2026
Summary
Nevada Medicaid has ended coverage for Emergency Use Authorization COVID-19 products like Lagevrio, reduced vaccine administration fees from enhanced rates to $7.80, and limited at-home COVID-19 test coverage to 2 tests per 30 days at $6.85 per test. These changes reflect the end of mandatory COVID-19 coverage following the Public Health Emergency.
Action Required
Immediately: Billing team must stop billing Nevada Medicaid for Emergency Use Authorization COVID-19 products like Lagevrio as they are no longer covered. Update billing system to reflect reduced COVID-19 vaccine administration fee of $7.80 for pharmacist-administered vaccinations. For at-home COVID-19 tests, limit billing to 2 tests per 30-day period at maximum rate of $6.85 per test and discontinue use of standing order dated March 9, 2022.